ANI Pharmaceuticals | ANIP - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
AbbVie USD 4.22B 329M 2026-03
ANI Pharmaceuticals USD 114.5M 8.38M 2026-03
Aurora Cannabis CAD 8.22M 80.38M 2026-03
Canopy Growth CAD 62.98M 9.91M 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Heron Therapeutics USD 11.12M 795K 2025-12
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.46B 83M 2026-03
Omeros USD 33.16M 18.52M 2024-06
Perrigo USD 643.7M 103.7M 2026-03
Sun Pharmaceuticals INR 36.77B 348M 2025-12
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03